FR2868702B1 - Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant - Google Patents

Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant

Info

Publication number
FR2868702B1
FR2868702B1 FR0403740A FR0403740A FR2868702B1 FR 2868702 B1 FR2868702 B1 FR 2868702B1 FR 0403740 A FR0403740 A FR 0403740A FR 0403740 A FR0403740 A FR 0403740A FR 2868702 B1 FR2868702 B1 FR 2868702B1
Authority
FR
France
Prior art keywords
nicotinic acid
amide
depigmenting agent
base associated
sphingoid base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0403740A
Other languages
English (en)
Other versions
FR2868702A1 (fr
Inventor
Jean Claude Allart
Jean Marie Lefevre
Jacques Peyrot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Negma Lerads SA
Original Assignee
Negma Lerads SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Lerads SA filed Critical Negma Lerads SA
Priority to FR0403740A priority Critical patent/FR2868702B1/fr
Priority to US11/547,846 priority patent/US20070238764A1/en
Priority to PCT/FR2005/000864 priority patent/WO2005102337A2/fr
Priority to JP2007506814A priority patent/JP2007532521A/ja
Priority to CA002561393A priority patent/CA2561393A1/fr
Priority to EP05753773A priority patent/EP1737457A2/fr
Publication of FR2868702A1 publication Critical patent/FR2868702A1/fr
Application granted granted Critical
Publication of FR2868702B1 publication Critical patent/FR2868702B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0403740A 2004-04-09 2004-04-09 Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant Expired - Fee Related FR2868702B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0403740A FR2868702B1 (fr) 2004-04-09 2004-04-09 Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant
US11/547,846 US20070238764A1 (en) 2004-04-09 2005-04-08 Use of Sphingoid Base Associated with Nicotinic Acid or a Nicotinic Acid Amide in the Form of Depigmentation Agent
PCT/FR2005/000864 WO2005102337A2 (fr) 2004-04-09 2005-04-08 Utilisation d'une base sphingoïde associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant.
JP2007506814A JP2007532521A (ja) 2004-04-09 2005-04-08 脱色素剤の形の、ニコチン酸またはニコチン酸アミドと関連したスフィンゴイド塩基の使用
CA002561393A CA2561393A1 (fr) 2004-04-09 2005-04-08 Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant.
EP05753773A EP1737457A2 (fr) 2004-04-09 2005-04-08 Utilisation d'une base sphingoïde associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403740A FR2868702B1 (fr) 2004-04-09 2004-04-09 Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant

Publications (2)

Publication Number Publication Date
FR2868702A1 FR2868702A1 (fr) 2005-10-14
FR2868702B1 true FR2868702B1 (fr) 2006-12-22

Family

ID=34944649

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0403740A Expired - Fee Related FR2868702B1 (fr) 2004-04-09 2004-04-09 Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant

Country Status (6)

Country Link
US (1) US20070238764A1 (fr)
EP (1) EP1737457A2 (fr)
JP (1) JP2007532521A (fr)
CA (1) CA2561393A1 (fr)
FR (1) FR2868702B1 (fr)
WO (1) WO2005102337A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823671B1 (fr) * 2001-04-23 2004-01-09 Dermaconcept Jmc Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoide
FR2894961B1 (fr) * 2005-12-16 2008-05-16 Oreal Utilisation de ceramides pour depigmenter la peau
FR2906143B1 (fr) * 2006-09-21 2010-01-22 Etienne Pierre Dominiq Soudant Procede de traitement binaire cosmetique, pharmaceutique et dermatologique permettant de synchroniser ou de resynchroniser la peau et l'organisme entier
FR2906139A1 (fr) * 2006-09-21 2008-03-28 Davines France Sarl Procede de traitement binaire cosmetique destine a lutter contre le vieillissement cutane et compositions pour sa mise en oeuvre
CA2804830A1 (fr) * 2010-07-22 2012-01-26 The Procter & Gamble Company Procede d'amelioration de l'apparence de taches hyperpigmentees impliquant plusieurs principes actifs
JP5726481B2 (ja) * 2010-10-29 2015-06-03 日本精化株式会社 ヒドロキシニコチン酸又はその誘導体を含有する化粧料又は皮膚外用剤
DE102011109546A1 (de) * 2011-08-03 2013-02-07 Evonik Goldschmidt Gmbh Verwendung von Sphinganin zur Verbesserung des visuellen Erscheinungsbildes von Haut und Haar
KR20200131850A (ko) * 2018-03-09 2020-11-24 오큐소프트, 인코포레이티드 국소 피부 관리 조성물
FR3100129A1 (fr) * 2019-08-26 2021-03-05 Laboratoire Promicea Nouvelle composition anti-taches d’hyperpigmentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1370236A (en) * 1972-01-11 1974-10-16 Unilever Ltd Skin composition
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
EP1063964A1 (fr) * 1998-03-16 2001-01-03 The Procter & Gamble Company Compositions d'hydratation
JP2001010926A (ja) * 1999-06-28 2001-01-16 Kao Corp 美白剤
FR2823671B1 (fr) * 2001-04-23 2004-01-09 Dermaconcept Jmc Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoide

Also Published As

Publication number Publication date
US20070238764A1 (en) 2007-10-11
EP1737457A2 (fr) 2007-01-03
WO2005102337A3 (fr) 2005-12-29
CA2561393A1 (fr) 2005-11-03
FR2868702A1 (fr) 2005-10-14
JP2007532521A (ja) 2007-11-15
WO2005102337A2 (fr) 2005-11-03

Similar Documents

Publication Publication Date Title
LU92565I2 (fr) Bromure d'umeclidinum
FR2868478B1 (fr) Structure de refroidissement d'un bloc-cylindres
MA29027B1 (fr) Procedes de renaturation d'anticorps recombinants
MA28802B1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
DE602005011795D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
DK1692242T3 (da) Viskoelastisk syre
DK1163239T3 (da) Modificerede aminosyreamider som CGRP-antagonister
DE602004025494D1 (de) Flüssiges cyclohexantricarbonsäureanhydrid
FR2868702B1 (fr) Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant
ATE384530T1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
DE602004023421D1 (de) Spalthakenbefestigungselement
EP1673384A4 (fr) Composes d'acide glutamique nitroses, leurs compositions et procedes d'utilisation
DE602004002056D1 (de) Fixation d'un coussin gonflable
DK1594859T3 (da) Indazolamider med analgetisk aktivitet
GB2420821B (en) Improved builders' trestles
FR2842105B1 (fr) Localisation des genes impliques dans la canitie precoce
ATE519860T1 (de) Verwendung von ribozymen zur detektion ebenfalls vorhandener agenzien
DE602004031534D1 (de) Stabiler polymorph von bifeprunoxmesilat
FR2875233B1 (fr) Joint autoadhesif et procede d'adhesivage
FR2866666B1 (fr) About d'echafaudage
FR2866893B1 (fr) Utilisation du 1,1,2,2-tetramethoxyethane a titre d'agent de coalescence
FR2851245B1 (fr) Emulsion non gelee d'hydroxyperoxyester
FR2804243B1 (fr) Regeneration d'anodes d'ecran plat de visualisation
FR2866147B3 (fr) Terminal d'ordinateur
UA10619S (uk) Комплект етикеток «маракуйя-лічі»

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20161230